Become a member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Online

May 15, 2017 12:00 PM - May 18, 2017 1:30 PM

Basics of the IND

Back to Agenda

Part 1

Session Chair(s)

Elliott Berger, PhD, MS

Elliott Berger, PhD, MS

President

ETB Regualtory Consulting, United States

The Drug Development Process: An Overview

Regulation Highlights
Key Definitions
Drug Development Highlights
Regulatory Strategy

The IND – A General Introduction

What is an IND
When is an IND Required/Not Required
Types of INDs

Questions/Answers

Have an account?